11-44275396-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_021926.4(ALX4):​c.729G>A​(p.Ala243Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 1,614,110 control chromosomes in the GnomAD database, including 10,043 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.099 ( 811 hom., cov: 33)
Exomes 𝑓: 0.11 ( 9232 hom. )

Consequence

ALX4
NM_021926.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.84

Publications

13 publications found
Variant links:
Genes affected
ALX4 (HGNC:450): (ALX homeobox 4) This gene encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones, limbs, hair, teeth, and mammary tissue. Mutations in this gene cause parietal foramina 2 (PFM2); an autosomal dominant disease characterized by deficient ossification of the parietal bones. Mutations in this gene also cause a form of frontonasal dysplasia with alopecia and hypogonadism; suggesting a role for this gene in craniofacial development, mesenchymal-epithelial communication, and hair follicle development. Deletion of a segment of chromosome 11 containing this gene, del(11)(p11p12), causes Potocki-Shaffer syndrome (PSS); a syndrome characterized by craniofacial anomalies, cognitive disability, multiple exostoses, and genital abnormalities in males. In mouse, this gene has been shown to use dual translation initiation sites located 16 codons apart. [provided by RefSeq, Oct 2009]
ALX4 Gene-Disease associations (from GenCC):
  • parietal foramina 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • frontonasal dysplasia with alopecia and genital anomaly
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet
  • parietal foramina
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 11-44275396-C-T is Benign according to our data. Variant chr11-44275396-C-T is described in ClinVar as Benign. ClinVar VariationId is 304704.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALX4NM_021926.4 linkc.729G>A p.Ala243Ala synonymous_variant Exon 2 of 4 ENST00000652299.1 NP_068745.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALX4ENST00000652299.1 linkc.729G>A p.Ala243Ala synonymous_variant Exon 2 of 4 NM_021926.4 ENSP00000498217.1

Frequencies

GnomAD3 genomes
AF:
0.0993
AC:
15106
AN:
152120
Hom.:
810
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0765
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.103
Gnomad ASJ
AF:
0.108
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0336
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.123
Gnomad OTH
AF:
0.120
GnomAD2 exomes
AF:
0.0899
AC:
22601
AN:
251386
AF XY:
0.0902
show subpopulations
Gnomad AFR exome
AF:
0.0751
Gnomad AMR exome
AF:
0.0669
Gnomad ASJ exome
AF:
0.105
Gnomad EAS exome
AF:
0.00141
Gnomad FIN exome
AF:
0.101
Gnomad NFE exome
AF:
0.123
Gnomad OTH exome
AF:
0.112
GnomAD4 exome
AF:
0.107
AC:
155880
AN:
1461872
Hom.:
9232
Cov.:
35
AF XY:
0.105
AC XY:
76393
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0753
AC:
2522
AN:
33480
American (AMR)
AF:
0.0713
AC:
3188
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2741
AN:
26134
East Asian (EAS)
AF:
0.000907
AC:
36
AN:
39700
South Asian (SAS)
AF:
0.0365
AC:
3151
AN:
86256
European-Finnish (FIN)
AF:
0.0995
AC:
5316
AN:
53414
Middle Eastern (MID)
AF:
0.190
AC:
1095
AN:
5768
European-Non Finnish (NFE)
AF:
0.118
AC:
131448
AN:
1112000
Other (OTH)
AF:
0.106
AC:
6383
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8427
16854
25282
33709
42136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4582
9164
13746
18328
22910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0993
AC:
15110
AN:
152238
Hom.:
811
Cov.:
33
AF XY:
0.0960
AC XY:
7150
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0765
AC:
3179
AN:
41538
American (AMR)
AF:
0.103
AC:
1572
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.108
AC:
374
AN:
3470
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5182
South Asian (SAS)
AF:
0.0332
AC:
160
AN:
4824
European-Finnish (FIN)
AF:
0.102
AC:
1082
AN:
10614
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.123
AC:
8351
AN:
67992
Other (OTH)
AF:
0.118
AC:
250
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
702
1403
2105
2806
3508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
937
Bravo
AF:
0.100
Asia WGS
AF:
0.0240
AC:
85
AN:
3478
EpiCase
AF:
0.126
EpiControl
AF:
0.126

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parietal foramina 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.037
DANN
Benign
0.44
PhyloP100
-3.8
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11037928; hg19: chr11-44296946; COSMIC: COSV61324527; API